Review: clinical and laboratory approach to the management of neutrophil dysfunction.
D000328:Adult; D002448:Cell Adhesion; D002462:Cell Membrane / Q000502:physiology; D002609:Chediak-Higashi Syndrome / Q000097:blood; D002634:Chemotaxis, Leukocyte; D003167:Complement Activation; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood; D006105:Granulomatous Disease, Chronic / Q000097:blood; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007231:Infant, Newborn; D007970:Leukopenia / Q000628:therapy*; D008262:Macrophage Activation; D008297:Male; D008854:Microscopy, Electron; D009504:Neutrophils / Q000502:physiology* / Q000648:ultrastructure; D009895:Opsonin Proteins / Q000502:physiology; D010084:Oxidation-Reduction; D010544:Peroxidases / Q000172:deficiency; D010585:Phagocyte Bactericidal Dysfunction / Q000628:therapy*; D010587:Phagocytosis
D009895:Opsonin Proteins; D010544:Peroxidases